Embricon Ltd was established in 2005 and is classified by Enterprise Ireland as a High Performance Start-Up (HPSU) company focused on the research, development and commercialisation of innovative Endovascular Solutions. The company is based at the Business Innovation Centre at the National University of Ireland, Galway. The three principals of the company who form the current Board of Directors bring together many years of world class experience in endovascular surgery, biomedical engineering, successful commercialisation expertise and entrepreneurial business success to promote the development of high value medical solutions.
Identification of the need for more effective surgical solutions, along with development of innovative concepts to commercialise and meet those needs, is seen as core competences of company.
Over the past eighteen months Embricon has combined its considerable clinical, technical and business knowledge and experience to identify several product opportunities in peripheral vascular surgery. The research carried out into varicosis has identified an opportunity to bring to market, in a moderate time period, a product that can satisfy a very significant market need. Having evolved the product concept ideas based upon continuous feedback from clinical procedural experience the company is now ready to move into the product development stage.
The company has identified a pipeline of complimentary vascular product concepts and intends to use the initial product as the catalyst to develop a portfolio of innovative peripheral vascular products in the future. The company is now actively exploring financing options to progress the initial project through development and into the market by 2009.
|
